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Abstract
Background/Aims: microRNAs (miRNAs) are small noncoding RNAs that regulate cognate mRNAs post-transcriptionally.
Human embryonic stem cells (hESC), which exhibit the characteristics of pluripotency and self-renewal, may serve as a
model to study the role of miRNAs in early human development. We aimed to determine whether endodermally-
differentiated hESC demonstrate a unique miRNA expression pattern, and whether overexpression of endoderm-specific
miRNA may affect hESC differentiation.
Methods: miRNA expression was profiled in undifferentiated and NaButyrate-induced differentiated hESC of two lines, using
microarray and quantitative RT-PCR. Then, the effect of lentiviral-based overexpression of liver-specific miR-122 on hESC
differentiation was analyzed, using genomewide gene microarrays.
Results: The miRNA profiling revealed expression of three novel miRNAs in undifferentiated and differentiated hESC. Upon
NaButyrate induction, two of the most upregulated miRNAs common to both cell lines were miR-24 and miR-10a, whose
target genes have been shown to inhibit endodermal differentiation. Furthermore, induction of several liver-enriched
miRNAs, including miR-122 and miR-192, was observed in parallel to induction of endodermal gene expression. Stable
overexpression of miR-122 in hESC was unable to direct spontaneous differentiation towards a clear endodermal fate, but
rather, delayed general differentiation of these cells.
Conclusions: Our results demonstrate that expression of specific miRNAs correlates with that of specific genes upon
differentiation, and highlight the potential role of miRNAs in endodermal differentiation of hESC.
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Introduction
microRNAs (miRNAs) are endogenous ,22-nucleotide non-
coding RNAs, known to regulate the expression of target genes by
at least two mechanisms–degradation of target mRNA transcripts
[1–4] and inhibition of mRNA translation [5]. More than 700
human miRNAs have been identified so far according to miRBase
release 10.0 (http://microrna.sanger.ac.uk/sequences/). Both the
biogenesis and action of miRNAs rely on components of the RNA
interference machinery, with several distinctions (for a compre-
hensive review see [6]). Systematic analysis of the spatial
expression of miRNAs has shown that many miRNAs are
expressed in a tissue-specific manner [7,8]. While the functions
and target genes of most miRNAs are still unknown, miRNAs
have been engaged in many different functions, including
developmental timing, patterning and embryogenesis, differentia-
tion and organogenesis, growth control and apoptosis and may
also be required for stem cell maintenance (reviewed in [9]).
Human embryonic stem cells (hESC) are derived from the inner
cell mass of the human blastocyst, and are characterized by
pluripotency and self renewal [10,11]. Thus, hESC may serve as a
model of early human embryology, and provide insights into
human developmental processes [12].
Characterizations of miRNA expression in mouse [13–16] and in
human [17–20] ES cells and ESC-derived embryoid bodies have
been recently published, and revealed two highly-expressed clusters
(miR-302 and mmu-miR-290/hsa-miR-371/372/373). Further-
more, specific miRNAs were proposed to modulate differentiation
of mouse ES cells in recent studies [21,22], but the role of miRNAs in
the regulation of stem cell growth and differentiation is poorly
understood. Likewise, data on miRNA function in human ES cell
differentiation is particularly scarce. miRNA expression has been
PLoS ONE | www.plosone.org 1 November 2008 | Volume 3 | Issue 11 | e3726characterized in hESC-derived embryoid bodies, containing cells of
allthree germlayers(endoderm,ectodermandmesoderm).However,
characterization of miRNA expression in models of directed hESC
differentiation has been published only for one protocol of
differentiation towards extraembryonic endoderm [20], and a
potential role for miRNAs in hESC differentiation has not yet been
investigated.
In the present work, we performed a genome-wide analysis of
miRNA expression in undifferentiated hESC and in hESC
differentiated in the presence of NaButyrate (NaB), which was
shown to promote endodermal differentiation [23,24]. We further
analyzed the effect of over-expression of the endoderm-specific
miR-122 on spontaneous differentiation of hESC.
Materials and Methods
ES Cell Culture and Differentiation
Human ES cell lines, HES-1 and HES-2 [10], were cultured on
human feeders (foreskin) in 85% Knockout (KO) DMEM medium
supplemented with 15% KO-serum replacement, 1 mM L-
glutamine, 50 U/mL penicillin, 50 mg/mL streptomycin, 1%
nonessential amino acids (Gibco-BRL, Gaithersburg, MD) and
4 ng/mL basic fibroblast growth factor (bFGF, Cytolab, Rehovot,
Israel) as described [25]. These ES cell lines were passaged every 6–
7 days using 1 mg/mL type IV collagenase (Gibco). For the
experiments we used cells from passages 18–40, which maintained a
normal karyotype throughout the experiments. Both lines expressed
the hESC markers, Oct4, SSEA-4 and Tra-1-81, in at least 80% of
the cells, as determined by flow cytometry analysis (data not shown).
For differentiation, cells were transferred from feeders to human
fibronectin-coated dishes (12.5 mg/cm
2, BD Biosciences, Bedford,
MA) and grown in the same culture medium that was conditioned
with the feeder cells for 24 hr prior to use. After three days, the
medium was replaced with unconditioned medium without bFGF,
supplemented with 0.5 mM NaButyrate (Sigma, St. Louis, MO) for
directed differentiation, or without NaB for control spontaneous
differentiation. Cells were harvested after seven or fourteen days
with EDTA (Gibco) for total RNA isolation. Neural spheres were
derived from HES1 cells as described [26].
RNA Isolation
Total RNA was isolated from cells or tissues (human liver tissues
were obtained under IRB approval) with Trizol reagent (Invitro-
gen, Carlsbad, CA) according to the manufacturer’s instructions,
except that RNA precipitation was performed with ethanol.
MicroRNA Microarray
MicroRNA expression analysis was performed as previously
described [27]. Briefly, cRNA was derived from adaptor-ligated to
100 mg size-fractionated RNA from each sample. Following
amplification, the double-stranded cDNA, carrying a T7 RNA
polymerase promoter on the 39 adaptor, was used for the labeling
reaction. Labeled cRNA (lcRNA) incorporating either Cy3 or Cy5
was purified through a G-50 column and hybridized under
standard conditions with custom microarrays by Agilent Technol-
ogies. The custom array design was as described [28], including
oligonucleotides matched to validated human microRNA (Sanger
Rfam registry) and thousands of Rosetta Genomics predicted
microRNAs. Raw signals vary from a minimal signal of ,50 to a
saturated signal of ,50,000. All probes were directed against
human miRNAs, and the prefix ‘hsa’ was either present or not in a
miRNA name only for the sake of convenience. Expression data
from the microarray was normalized using polynomial fitting.
First, the mean expression level for each miRNA in all
experiments was calculated, and then a 2
nd degree polynomial
function F for fitting each experiment signals to the calculated
mean expression was found. The normalized signal for each
miRNA in each experiment is the result of F(x), where F is the
specific function for the specific experiment. Only validated
miRNAs (published and predictions of Rosetta Genomics,
designated as MIDxxx) probes were used for the normalization
(the minority of probes).
microRNA cloning and sequencing
Few of Rosetta predicted microRNAs that had high expression
on the microarrays were cloned as previously described [28].
Briefly, biotinylated capture oligonucleotides (22–30 nucleotides
long, with biotin at the 59 end) were hybridized to an aliquot (5 ml)
of the library in TEN buffer. mMACS Streptavidin Microbeads
were then added and the reaction was incubated for 2 min at the
hybridization temperature. Mixture was loaded onto a magnetized
mMACS Streptavidin Kit column and hybridized single-stranded
library molecules were eluted by adding 150 ml of water preheated
to 80uC. The single-stranded cDNA library molecules were
recovered, amplified by PCR, ligated into a pTZ57R/T vector
and transformed into JM109 bacteria. Positive colonies were
identified and sequenced.
cDNA Macroarray
cDNA macroarrays containing probes for 83 genes (including
undifferentiated hESC and hepatic markers and endogenous
controls) were fabricated as described [29]. Briefly, cDNA probes
for 83 genes were amplified by RT-PCR, cloned into TOPO-TA
vector (Invitrogen), sequence-verified, and spotted on nylon
membranes (GeneScreen
TM, NEN, Boston, MA). 5 mg of total
RNA from each sample were labeled with dCTPaP
33, and
hybridized with the membrane as described [29]. Gene expression
was quantified using VisualGrid
TM software and the Matlab
TM
program ‘‘MembraneProcess’’ [29]. Average results of two
independent experiments were used.
Algorithm for Prediction of Regulation of miRNAs by
Transcription Factors
In order to predict regulation of miRNAs by transcription
factors the following algorithm was used. First, a binary value was
declared for each transcription factor (TF) in each sample as
expressed/unexpressed, based on the results of the cDNA
macroarray (background threshold was considered as 0.01 for
this analysis). Then, a binary value was declared for each miRNA
in each sample as expressed/unexpressed, based on the results of
the miRNA microarray (background threshold was variable and
estimated manually for each sample). For each TF, a list of
miRNAs which were co-expressed with the TF in all the samples
was compiled. For example, if TF A was expressed in sample 1 but
not in the other samples, then all the miRNAs which were
expressed in sample 1 and not expressed in the other samples were
considered as co-expressed with this TF. In these cases, the TF was
predicted to serve as an activator. In cases of anti-correlation
between the TF expression and the miRNA expression, the TF
was predicted to serve as a repressor. For prediction of TF binding
to miRNA promoter, a transcription start site (TSS) was predicted
for all miRNAs using annotated genes, mRNAs, ESTs, Paired End
Tags (PET) sequences, and CpG islands downloaded from the
UCSC genome browser (http://genome.ucsc.edu/). Promoter was
predicted similarly to what was described by [30]. All predicted
transcription factor binding sites taken from the UCSC genome
browser (TFBS track representing Transfac data) were searched in
miRNAs in Endodermal hESC
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downstream to the TSS, to yield a dataset of all miRNAs and the
TFs capable of binding to their promoters (unpublished dataset).
Lastly, for each co-expressed or anti-correlated miRNA/TF pair,
we tested whether the TF could directly bind to the miRNA
promoter according to the above dataset. TF/miRNA pairs, in
which the miRNA was derived from a poly-cistronic miRNA
cluster, were included only in the case that all miRNAs derived
from this cluster were co-expressed or anti-correlated with the TF.
Vector Design and Virus Production
Construction of a lentiviral vector expressing enhanced yellow
fluorescent protein (EYFP) reporter fused to the 39UTR of miR-122
target gene CAT1 [31] was performed as follows: First, the human
PGK promoter-EGFP cassette from pRLLSIN18.hPGK.EGFP
[32,33] was inserted into ECORV and Bsp1407I sites of
pSIN18.cPPT.hEF1ap.EGFP.WPRE [34]. Then, by digestion of
the resulted plasmid with Bsp1407I and BamHI, the EGFP cassette
was replaced with a polylinker containing HpaI site, to generate
pSIN18.cPPT.hPGKp.linker.WPRE. Finally, an Eco47III and HpaI
fragment of EYFP-CAT1 cassette derived from plasmid CAT1 in
pEYFP Stop was inserted into HpaI site of pSIN18.cPPT.hPGK-
p.linker.WPRE to generate pSIN18.cPPT.hPGKp.EYFP-CAT1.
WPRE.
For construction of a lentiviral vector expressing miR-122, the
human H1 promoter (position -220 to +1) was amplified by PCR and
subcloned into pBS as described [35]. The promoter was then
digested with XhoIa n dECORV and inserted into viral vector
pSIN18.cPPT.hEF1ap.RFP.WPRE [35] to generate pSIN18.
cPPT.H1p.hEF1ap.RFP.WPRE. The genomic sequence encoding
hsa-miR-122 (a 277-base fragment) was amplified by PCR from
plasmid 122 in pCMV using primers: 59-AACCATCGA-
TATGCTTCTTTTCTCTGCTTAGG (ClaI), and 59-AAAAG-
TACTAAAAACAAGATTGAGAAGACTGATATC (ScaI). The
amplified fragment was cloned into the ClaIa n dECORV sites of
pSIN18.cPPT.H1p.hEF1ap.RFP.WPRE to generate pSIN18.
cPPT.H1p.miR-122.hEF1ap.RFP.WPRE. For generation of mutat-
ed miR-122-expressing vector, three mutations in the seed sequence
(atpositions2, 4 and 6)wereintroducedby PCR. Thesequenceofthe
miRNA was amplified from pSIN18.cPPT.H1p.miR-122.hE-
F1ap.RFP.WPRE by PCR using primers: 59-GAGGTGAAGT-
TAACACCTTCGTGGCTACAGAGTTTCCTTAGCAGAGC-
TGTCGTGAGTGACAATGGTGTTT (HpaI), and 59-GATTGA-
GAAGACTGATATCAGATGAACCTT (ECORV) and recloned
into sites HpaIa n dECORV of this vector. The basic vector
pSIN18.cPPT.H1p.hEF1ap.RFP.WPRE served as an empty vector.
All vectors were sequence-verified. Recombinant virions of miR-122-
expressing vectors were produced and concentrated as previously
described [34].
Transduction of hESC
At the time of routine passage, hESC were dissociated into a
single cell suspension by EDTA (Gibco) and plated in a feeder-
covered 6-well tissue culture plate at a concentration of 1610
5 per
well. The next day, the medium was replaced and supplemented
with the concentrated virus, in the presence of 5 mg/ml polybrene
(Sigma). The medium was replaced with fresh hESC culture
medium one day following transduction.
DNA Microarrays
Gene expression profiling was performed using the Affymetrix
Human Genome U133A 2.0 Array (Santa Clara, CA), comprised
of ,22,000 probe sets representing 18,400 transcripts and
variants, including 14,500 well-characterized human genes,
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miRNAs in Endodermal hESC
PLoS ONE | www.plosone.org 3 November 2008 | Volume 3 | Issue 11 | e3726Figure 1. miRNA expression analysis in undifferentiated and differentiated hESC. A–C. Scatter plots representing miRNA expression
profiles of 436 miRNAs in undifferentiated and 14d-differentiated HES1 and HES2 cells. Names of outlier miRNAs are indicated. miRNA names in the
format MIDxxx are predictions of Rosetta Genomics. D. Unsupervised hierarchical cluster analysis was performed on expression signature of 436
human miRNAs in undifferentiated (undiff) HES1 and HES2 cells, and in cells differentiated (diff) with NaB for 7d or 14d (Cluster 3.0 software, log
transformed data, average linkage). A dendogram demonstrating similarity level in miRNA expression between the various samples is shown. E. Venn
diagrams of 20% of the miRNAs with the highest expression level for each cell line in undifferentiated (undiff), 7d-differentiated (7d diff) and 14d-
differentiated (14d diff) HES1 and HES2 cells. Number of miRNAs included in each circle is denoted in parentheses.
doi:10.1371/journal.pone.0003726.g001
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PLoS ONE | www.plosone.org 4 November 2008 | Volume 3 | Issue 11 | e3726according to the manufacturer’s instructions. Data was normalized
using RMA software (R2.1.0 package) and analyzed using
SpotfireDecisionSite
TM software for functional genomics. For
analysis of gene expression in RNA from differentiated hESC
expressing miR-122, average results of three (mutant miRNA) or
two (wt miRNA) independent experiments were used. The
datasets have been deposited in NCBI’s Gene Expression
Omnibus [36] and are accessible through GEO Series accession
number GSE13460 (,http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE13460.).
Flow Cytometry
Cells were harvested for fluorescence-activated cell sorter (FACS)
analysis with EDTA (hESC) or 0.25% Trypsin/1 mM EDTA
(HEK-293 cells) (both from Gibco) , and suspended in phosphate–
buffered saline containing 2% fetal calf serum and 0.1% sodium
azide. The cells were analyzed on a FACSCalibur system (Becton-
Dickinson, San Jose, CA) using the CellQuest
TM software.
Real-time Quantitative Polymerase Chain Reaction
For mature microRNA quantification, a two-step protocol
including reverse transcription with a miRNA-specific primer and
TaqMan MicroRNA Reverse Transcription Kit, followed by real-
time PCR with TaqMan assays (human) and Taqman PCR
Master Mix Kit, was applied on ten nanograms of total RNA for
each sample (all reagents were purchased from Applied Biosystems
[ABI], Foster City, CA), and reaction protocols were carried out
according to the manufacturer’s instructions. For mRNA quan-
tification, 2.5 mg of total RNA were reverse transcribed using
random hexamer primer and Moloney murine leukemia virus
reverse transcriptase RNase H minus (both from Promega,
Madison, WI). cDNA was amplified with Fast Taqman PCR
Master Mix Kit and inventoried human Taqman assays (both
from ABI), according to the manufacturer’s instructions.
The reactions for miRNA and mRNA were automated by a
7900HT Fast Real-Time PCR System (ABI). Each PCR reaction
was performed in triplicate and the average ct was used for RQ
calculation after normalization to RNU43 (for miRNAs) and
human GUSB (for mRNAs) (both from ABI).
Statistical Analysis
Data is expressed using the mean and the standard deviation
when at least two independent experiments were performed.
Student’s t test was used for performing analysis of variance in
Excel software. A p value of 0.05 or less was considered statistically
significant.
Results and Discussion
Characterization of miRNA expression in undifferentiated
hESC
We first characterized the miRNA expression profile of our
undifferentiated hESC lines and compared it with published data.
To this end, we extracted RNA from two different hESC lines
(HES1 and HES2 [10]) and subjected it to miRNA expression
profiling of 436 human miRNAs using specialized miRNA
microarrays [28] (Table S1). During the miRNA profiling we
discovered three novel miRNAs, one of which was first cloned in
undifferentiated HES2 cells and whose expression level changed
upon differentiation (Table 1). The expression level of these novel
miRNAs was not consistent in our two cells lines, and additional
experiments are needed in order to clarify whether these miRNAs
play a role in hESC differentiation. Examination of the miRNA
expression profiles of HES1 versus HES2 cells (Fig. 1A) revealed
Table 2. The top 10% miRNAs expressed in undifferentiated
hESC
HES1 HES2
1 hsa-miR-21 hsa-miR-21
2 hsa-miR-302a hsa-miR-302a
3 hsa-miR-302b hsa-miR-302b
4 hsa-miR-302c hsa-miR-302c
5 hsa-miR-372 hsa-miR-372
6 hsa-miR-92a hsa-miR-302d
7 hsa-miR-302d hsa-miR-125b
8 hsa-miR-125b hsa-miR-221
9 hsa-miR-296-5p hsa-miR-205
10 hsa-miR-221 hsa-miR-92b
11 hsa-miR-205 hsa-miR-25
12 hsa-miR-92b hsa-miR-106a
13 hsa-miR-25 hsa-let-7b
14 hsa-miR-222 hsa-miR-30c
15 hsa-miR-15b hsa-miR-92a
16 hsa-miR-106a hsa-miR-222
17 hsa-miR-30d hsa-miR-199a-5p
18 hsa-miR-27b hsa-miR-27b
19 hsa-miR-191 hsa-miR-15b
20 hsa-miR-512-3p hsa-miR-125a-5p
21 hsa-miR-17 hsa-miR-17
22 hsa-miR-517b hsa-miR-191
23 hsa-miR-19b hsa-miR-30d
24 hsa-miR-125a-5p hsa-miR-93
25 hsa-miR-30c hsa-miR-182
26 hsa-miR-505 hsa-miR-505
27 hsa-miR-331-3p hsa-miR-19b
28 hsa-miR-26a hsa-miR-26a
29 hsa-miR-151-3p hsa-miR-148a
30 hsa-miR-182 hsa-miR-30a
31 hsa-miR-197 hsa-miR-151-3p
32 hsa-miR-371-3p hsa-miR-339-5p
33 hsa-miR-339-5p hsa-miR-331-3p
34 hsa-miR-520f hsa-miR-214
35 hsa-miR-328 hsa-miR-197
36 hsa-miR-142-3p hsa-miR-200c
37 hsa-miR-326 hsa-miR-517b
38 hsa-miR-93 hsa-miR-512-3p
39 hsa-miR-148a hsa-miR-345
40 hsa-miR-302c* hsa-miR-199a-3p
41 hsa-miR-363 hsa-miR-328
42 hsa-miR-130b* hsa-miR-30e
43 hsa-miR-373 hsa-miR-326
44 hsa-miR-199a-5p hsa-miR-20b
The top 10% of miRNAs expressed at the highest level are shown for each cell
line, in a descending order of expression. miRNAs that appear in both cell lines
are bolded.
doi:10.1371/journal.pone.0003726.t002
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miR-372 and members of the cluster 302. Table 2 lists the
miRNAs with the highest expression levels for each cell line. 82%
of these miRNAs were highly-expressed in both lines. These results
are consistent with previous reports [13,17], and show that
undifferentiated hESC express a unique set of miRNAs, including
two ESC clusters on chromosomes 4 (cluster 302) and 19 (cluster
371-3). We also detected high expression of members of the
nonconserved cluster (cluster 520) as in [20]. Notably, several of
the top expressed miRNAs (miR-93, cluster 520, cluster 302 and
cluster 372-3) contain the same seed sequence and are thus
predicted to target the same mRNAs (according to TargetScan
4.0). Co-expression of different miRNAs targeting the same genes
in the same tissue may confer higher efficiency and flexibility to
the miRNAs’ action.
Interestingly, we detected statistically significant enrichment of
oncomiR expression in our hESC lines, including members of the
paralogues clusters 17–92, 106a-92 and 106b-25 (hypergeometric
test, p,0.0005). Expression of proto-oncomiRs, engaged in
regulation of cell cycle, may be expected in hESC, as hESC has
an indefinite proliferation capacity.
Effect of NaButyrate-induced differentiation of hESC on
miRNA expression
The histone deacetylase inhibitor, NaButyrate (NaB) was shown
to induce endodermal [23] and hepatic-like [24] differentiation of
both hESC and embryonal carcinoma cells [36]. We sought to
induce endodermal differentiation by a 7 and 14 day (d) treatment
with NaB.
Cluster analysis of miRNA expression uncovered a distinct
fingerprint for undifferentiated and NaB-differentiated hESC (Table
S1 and Fig. 1B–D). Nonetheless it is worthwhile noting that there
were cell-line specific profiles, similar to what was recently
demonstrated by Melton and colleagues [37]. A substantial overlap
in miRNA expression before and after NaB differentiation (Fig. 1E),
including persistence of theESC-specificcluster 302, may suggestthat
our protocol only partially pushes the cells towards differentiation.
Among the downregulated (Table 3) miRNAs were ESC-
enriched miRNAs such as cluster 302 and miR-106a [13,14],
miR-17-5p [17] and miR-124 [13,17]. In the adult, miR-124 is
expressed specifically in the brain [7], and its downregulation may
suggest that neural differentiation was probably not promoted by
NaB treatment. miR-24 was predominantly upregulated in both
lines (Table 3). A miR-24 validated target is Notch1 [38]. Notch-
signaling was shown to inhibit endoderm formation in zebrafish
[39], and hence, it is intriguing to consider miR-24 involvement in
repression of Notch signaling as a component in promoting
endodermal differentiation. miR-10a, yet another miRNA to be
upregulated byNaBtreatmentinboth lines,is upstream ofHOXA1
[40]. HoxA1 was proposed to mediate repression of endodermal
differentiation [41], which is consistent with higher expression of
endodermal markers in Hoxa1
2/2 mouse ES cells. Thus, induction
of miR-10a and miR-24 in response to NaB may contribute to
endodermal differentiation via HOXA1 and Notch repression.
Table 3. miRNAs upregulated and downregulated upon hESC differentiation
Upregulated miRNAs
HES1 HES2
miRNA ID 7d diff/undiff 14d diff/undiff miRNA ID 7d diff/undiff 14d diff/undiff
hsa-miR-24 71.93 72.06 hsa-miR-375 13.09 34.76
hsa-let-7b 31.48 42.25 hsa-miR-10a 2.60 34.10
hsa-miR-10a 2.22 13.96 hsa-miR-24 14.98 30.29
hsa-let-7c 2.54 12.49 hsa-miR-218 3.06 12.67
hsa-miR-346 69.70 12.33 hsa-miR-122 2.05 8.81
hsa-let-7d* 89.86 11.25 hsa-miR-371-3p 12.44 8.74
MID363 10.25 10.45 hsa-miR-371-5p 10.49 8.11
hsa-miR-15a* 9.16 9.18 hsa-miR-373 14.96 7.26
hsa-miR-188-3p 2.51 8.98 hsa-miR-30b 1.41 6.26
hsa-miR-509-3p 110.20 8.25 hsa-miR-500* 2.15 4.01
Downregulated miRNAs
hsa-miR-200c 0.08 0.09 hsa-let-7i 0.12 0.07
hsa-miR-107 0.09 0.14 hsa-miR-302c* 0.76 0.10
hsa-miR-17 0.05 0.15 hsa-miR-409-3p 0.18 0.12
hsa-miR-20b 0.04 0.15 hsa-miR-187 0.21 0.14
hsa-miR-106a 0.04 0.16 hsa-miR-142-3p 0.15 0.14
hsa-miR-301a 0.18 0.18 hsa-miR-520f 1.51 0.15
hsa-miR-423-5p 0.87 0.18 hsa-miR-654-3p 0.19 0.15
hsa-miR-124 0.14 0.19 hsa-miR-485-3p 0.15 0.15
hsa-miR-20a 0.22 0.20 hsa-miR-302d 1.16 0.18
hsa-miR-130a 0.12 0.20 hsa-miR-93 0.34 0.18
List of the top ten miRNAs upregulated or downregulated at least 2-folds in each line upon differentiation. Expression is presented as fold of change in 7d and 14d
differentiated (diff) versus undifferentiated (undiff) cells. miRNAs designated as MIDxxx are predictions of Rosetta Genomics.
doi:10.1371/journal.pone.0003726.t003
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PLoS ONE | www.plosone.org 6 November 2008 | Volume 3 | Issue 11 | e3726Figure 2. Verification of the miRNA microarray results by qRT-PCR. QRT-PCR results of miRNA expression level in undifferentiated HES1 and
HES2 cells or cells differentiated with NaB for 7d or 14d. Results are expressed as relative quantification of the miRNA expression level in each sample
relative to undifferentiated cells of the respective line, and normalized to RNU43. Each reaction was performed in triplicate and the average ct was
used for RQ calculation. RQ–Relative Quantification; Con–control cells grown with the same media as treated cells, but without NaB; NaB–0.5 mM Na
Butyrate; F–Feeder, mitotically arrested foreskin cells (feeder cells of hESC); EC–Embryonal Carcinoma 2102Ep cell line; EL–human embryonic livero f
stage 7w from gestation; AL–human normal adult liver; NS–Neurospheres, HES1 cells differentiated for 4.5w towards neural fate.
doi:10.1371/journal.pone.0003726.g002
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PLoS ONE | www.plosone.org 7 November 2008 | Volume 3 | Issue 11 | e3726Let-7b/c/d* family members were also upregulated upon
differentiation, an observation that nicely fits with the avoidance
of let-7 activity in ESCs [42].
The expression of endoderm-specific miRNAs–miR-375 [43],
and miR-122, [31] was upregulated in response to NaB, though to
a higher extent in the HES2 cell line. Induction of these miRNAs
Figure 3. Summary of miRNA expression in endodermal differentiation of hESC.
doi:10.1371/journal.pone.0003726.g003
Figure 4. Characterization of hepatic markers expression in hESC differentiated with NaB. cDNA macroarray results of gene expression
analysis in undifferentiated (undiff) HES1 and HES2 cells or cells treated with NaB for 7 or 14d, or with the basic medium only (con). The same RNA
samples that were utilized for miRNA profiling were used for this analysis. The average results of two independent experiments are presented as gene
expression level in arbitrary units. CK8-cytokeratin 8; CK18–cytokeratin 18; CK19–cytokeratin 19; AFP-alpha-fetoprotein; TTR-transthyretin; ALB–
albumin; ASGR1-asialoglycoprotein receptor 1; TDO2-tryptophan 2,3 dioxygenase; DLK1-Delta-like 1 Homolog.
doi:10.1371/journal.pone.0003726.g004
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PLoS ONE | www.plosone.org 8 November 2008 | Volume 3 | Issue 11 | e3726may indicate an endodermally-oriented differentiation of our cells,
as expected with NaB treatment.
Taken together, we suggest that miRNAs 10a, 24 and 122 mark
endodermal differentiation. According to the data of Laurent et
al., miR-122, miR-10a and miR-24 were upregulated in hESC
differentiated towards extraembryonic endoderm, while miR-
375’s expression was unchanged [20]. When comparing these
results to ours, it could be that miR-375’s upregulation further
allows for the distinction of definitive vs. extraembryonic
endoderm.
Next, we compared the miRNA expression in our NaB-treated
samples to that of adult liver. More specifically, we chose the most
tissue-specific human miRNAs, which are relatively abundant in
the liver, according to the miRNA atlas reported recently by
Tuschl and colleagues [44]. We discovered that of these five
miRNAs, miR-122 and miR-192 were upregulated at least 1.5-
fold in both HES1 and HES2 cells, while miR-135b and miR-33a
were upregulated only in HES2 cells, and miR-224 was
upregulated only in HES1 cells.
The expression pattern of eight miRNAs was verified by
quantitative (q) RT-PCR (Fig. 2). These miRNAs were differen-
tially-expressed upon NaB-induced differentiation and represent
ES miRNAs (hsa-miR-302a*, hsa-miR-302d, hsa-miR-517b),
endodermal miRNAs (hsa-miR-122, hsa-miR-375) and miRNAs
that were upregulated in both lines (hsa-miR-10a, hsa-miR-24).
Generally, the RT-PCR results confirmed the microarray results,
but the fold change was usually higher in the RT-PCR. Different
expression of these miRNAs in feeder cells compared to hESC and
hESC-derived cells showed that these expression patterns were not
a result of feeder cell contamination.
A summary of miRNA expression in hESC differentiated with
NaB is depicted in Figure 3. On the whole, many of the miRNAs
that were either upregulated or downregulated upon differentia-
tion are related to proliferation, an observation which is consistent
with NaB’s ability to affect cell cycle and proliferation [45]. Two of
the most upregulated miRNAs common to both of our cell lines
were miR-24 and miR-10a, whose target genes have been shown
to inhibit endodermal differentiation. Additional miRNAs that are
considered as relatively liver-specific or endoderm-specific, such as
miR-122, miR-192 and miR-375 were also induced in both lines
upon differentiation, albeit to a greater extent in HES2 cells.
Additional experiments should clarify whether these miRNAs play
a role in endodermal differentiation of hESC or in the embryo.
Characterization of hepatic gene expression in hESC
differentiated with NaB
To evaluate the level and fate of hESC upon differentiation
induced by NaB, we determined the expression profile of 83 hESC
and liver markers using a homemade cDNA macroarray. Results
of selected genes are presented in Figure 4. Oct4 (POU5F1), a
marker for undifferentiated hESC, was downregulated in cells
treated with NaB compared to undifferentiated cells. The
downregulation was more prominent in HES2 than in HES1
cells, in accordance with the more prominent downregulation of
ESC-specific miRNAs in differentiated HES2 cells. Cytokeratins
are markers of epithelium and are expressed in hepatocytes
(cytokeratine 8, 18) and cholangiocytes (cytokeratin 19), but are
not specific to the liver. All three markers were expressed at very
low levels in the undifferentiated cells, but were upregulated after
treatment with NaB, which may indicate that the differentiated
cells acquired an epithelial identity. Likewise, hepatic markers such
as alpha-fetoprotein (AFP) and transthyretin (TTR), which are also
expressed in extra-embryonic endoderm, were not expressed in
undifferentiated cells and were upregulated in response to NaB,
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PLoS ONE | www.plosone.org 9 November 2008 | Volume 3 | Issue 11 | e3726most prominently in HES2 cells after fourteen days. Hepatocyte-
specific markers such as albumin (ALB), asialoglycoprotein
receptor 1 (ASGPR1) and tryptophane 2, 3 dioxygenase (TDO2)
were also not expressed in undifferentiated cells, and all three
markers were upregulated in response to NaB. This upregulation
was more significant in HES1 cells after seven days and in HES2
cells after fourteen days. Expression of the embryonic liver marker
delta-like homolog 1 (DLK1) [46] was also upregulated in response
to NaB, yet again, to a much greater extent in HES2 cells. In
conclusion, the cells differentiated in response to NaB, as indicated
by the downregulation of Oct4, and seemed to gain an epithelial
identity and to express known liver markers. In response to NaB,
Figure 5. Overexpression of hsa-miR-122 in hESC. A. Schematic representation of the lentiviral vector expressing the wt and mutant hsa-miR-
122. The H1 and EF1a promoters are marked by an arrow. The sequence of mature wt miR-122 and mutant miR-122 carrying 3 mutations in the seed
sequence (underlined) are shown below. RFP-Red Fluorescent Protein; cPPT-central PolyPurine Tract; WPRE-Woodchuck hepatitis virus
Posttranscriptional Regulatory Element. B. HEK-293 cells were co-transfected with a lentiviral plasmid encoding EYFP fused to the 39UTR of hsa-
miR-122 target gene CAT-1 (EYFP-CAT-1) and lentiviral plasmids encoding wt hsa-miR-122, mutant (mut) hsa-miR-122 or empty vector (ev). 48 hr
later, the cells were analyzed for EYFP expression by FACS. Each transfection was performed in triplicate and the average mean fluorescence intensity
of each triplicate is presented with the SD. C. FACS histogram showing transduction efficiency of HES2 cells with lentiviral vector expressing hsa-miR-
122 (wt or mutant) and a RFP reporter. A representative histogram of two independent experiments is shown. D. QRT-PCR results of hsa-miR-122
expression levels in undifferentiated untransduced HES2 cells, or cells transduced with lentiviral vector encoding wt or mutant (mut) hsa-miR-122.
Results are expressed as relative quantification of the miRNA expression level in each sample relative to untransduced cells, and normalized to
RNU43. Each reaction was performed in triplicate and the average ct was used for RQ calculation.
doi:10.1371/journal.pone.0003726.g005
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PLoS ONE | www.plosone.org 10 November 2008 | Volume 3 | Issue 11 | e3726HES2 cells expressed more hepatic markers and at higher levels
compared to HES1 cells, in accordance with the differences in the
level of endodermal miRNA expression between these lines. In
addition, it seemed that for hepatic gene induction, fourteen days
was the preferred time period of NaB treatment for HES2 cells,
while a seven-day treatment was more favorable for HES1 cells.
These findings suggest that specific miRNA expression
correlates with specific gene expression in differentiated cells, as
was the case with undifferentiated hESC in the present study and
in others [16,18,19].
Prediction of transcription factors that affect miRNA
expression in differentiated hESC
In an effort to uncover the regulatory factors (activators and
repressors) responsible for the changes in miRNA expression upon
hESC differentiation, we compared our gene expression data with
the miRNA expression data. Towards this aim, we developed an
algorithm which allowed us to correlate between differentially-
expressed transcription factors (TFs) and miRNAs, and then for
each given pair of miRNA/TF, to search the promoter region for a
conserved binding site for the TF. The expression of eleven out of
twenty-one TFs included in our cDNA macroarray changed by at
least two-fold in at least one of our samples (not shown). Our
analysis predicted two activators and two repressors, which could
have affected our miRNA expression upon differentiation (Table 4).
One TF, CEBPA (C/EBPa), was predicted to affect miRNA
expression both positively and negatively, according to our results.
CEBPA is highly-expressed in the developingand adult liver, as well
as in additional metabolic tissues and the hematopoietic tissue,
where it controls differentiation-dependent gene expression and
inhibits cell proliferation ([47] and references therein). In line with
CEBPA’s known functions, our results predicted it to activate let-7c
and miR-125b, both of which are capable of inhibiting cell
proliferation [48,49], and in addition, to repress miR-130a, which
was shown to be involved in megakaryocytopoiesis [40]. Interest-
ingly, CEBPA, which was upregulated four-fold in our HES1 cells
upon differentiation, is predicted to be itself regulated by miR-124,
miR-25, miR-363 and miR-367 (among others) according to
TragerScan 4.2, all of which were downregulated at least 1.5-fold in
differentiated HES1 cells. Collectively, this data enhances our
understanding of regulation of hESC differentiation by miRNAs,
yet necessitates further support in additional targeted experiments.
The effect of miR-122 overexpression on hESC
differentiation
Some miRNAs may play a role in promoting and maybe even
directing differentiation. For example, it was recently shown that
overexpression of the brain-specific miR-124 in HeLa cells shifted
their gene-expression profile towards that of neurons, whereas
delivery of the muscle-specific miR-1 shifted the profile towards that
of muscle [50]. In line with these results, we tested whether
overexpression of a single miRNA in hESC will affect the
differentiation process. As demonstrated above, NaB treatment
induced the expression of liver-specific miR-122 in parallel to several
hepatic genes, mainly in HES2 cells. miR-122 is highly-expressed in
the developing and in the adult liver (Fig. 2 and [31]) and regulates
metabolic functions in the adult liver such as lipid metabolism [51]
and cholesterol biosynthesis [52]. Therefore, we sought to determine
whether overexpression of miR-122 may modify the mRNA profile
of HES2 cells towards a ’’liver-like’’ pattern. In order to overexpress
miR-122 or a control, which is mutated in 3 nucleotides within the
seed sequence, we used a lentiviral transduction-based method, which
was shown to enable stable and efficient transgene expression in
Figure 6. Effect of miR-122 overexpression on miRNA expres-
sion in hESC. QRT-PCR results of miRNA expression levels in
undifferentiated (undiff) untransduced (un-trans) HES2 cells, and in
cells transduced with wt or mutant (mut) miR-122 vector either
undifferentiated, or spontaneously differentiated for 14d. Results are
expressed as relative quantification of the miRNA expression levels in
each sample relative to untransduced cells, and normalized to RNU43.
Each reaction was performed in triplicate, and the average ct was used
for RQ calculation. For differentiated cells, average RQ of 3 independent
experiments is shown with the SD and the p value between mut diff
and wt diff cells.
doi:10.1371/journal.pone.0003726.g006
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PLoS ONE | www.plosone.org 11 November 2008 | Volume 3 | Issue 11 | e3726Figure 7. Effect of miR-122 overexpression on gene expression in hESC. QRT-PCR results of gene expression in 14d-differentiated HES2 cells
expressing mutant (mut) or wt miR-122. The reactions were performed on the same RNA samples that were analyzed on the microarrays. Results are
expressed as relative quantification of the gene level in each sample relative to undifferentiated cells transduced with the relevant miRNA (wt or
mutant), and normalized to GUSB. Each reaction was performed in triplicates and the average RQ of 3 independent experiments is shown with the SD
and the p value between mut diff and wt diff cells when significant.
doi:10.1371/journal.pone.0003726.g007
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PLoS ONE | www.plosone.org 12 November 2008 | Volume 3 | Issue 11 | e3726hESC [25,34]. We inserted the genomic sequence encoding human
hsa-miR-122 into a reporter-containing lentiviral vector, under the
constitutive polymerase III promoter H1 (Fig. 5A). We confirmed the
functionality of the cloned miR-122 by its ability to repress the
expression of an EYFP reporter gene fused to the 39UTR of a known
miR-122 target gene, CAT-1 [31]. Following transfection to HEK-
293 cells, wt miR-122 repressed the EYFP levels to 25% of the
expression level in the presence of mutant miR-122 or empty vector
(Fig. 5B). Transduction efficiency of both lentiviral vectors (encoding
wt and mutant miR-122) into HES2 cells was at least 80%, as judged
by the expression of the red fluorescent reporter protein (Fig. 5C).
QRT-PCR analysis revealed that miR-122 was highly expressed in
transduced HES2 cells compared to untransduced cells (Fig. 5D).
Apparently, the assay primers did not recognize the mutant miRNA
form, probably due to the three mismatches.
In order to evaluate the effect of miR-122 expression on
differentiation of hESC, we transferred the transduced HES2 cells
from feeder cells to fibronectin and allowed the cells to
differentiate spontaneously in the basic medium without bFGF
supplementation for fourteen days. miR-122 remained highly-
expressed during the differentiation process (Fig. 6A). We analyzed
the global gene expression of differentiated cells expressing either
wt or mutant miR-122 using Affymetrix microarrays (Table S2,
GEO accession GSE13460 [36]) and qRT-PCR.
Table S3 lists the 50 most differentially-expressed probes between
cells transduced with wt versus mutant miR-122. Strikingly, among
the genes that were upregulated in the presence of wt miR-122 were
HHEX, an early marker of embryonic liver [53], which play a
fundamental role in liver development [54] (Table S3 and Fig. 7A),
and CXCR4, a marker for definitive endoderm [55]. Interestingly,
out of the top 50 upregulated probes, 20% represented markers of
undifferentiated hESC, including POU5F1 (Oct4) [56], NANOG
[57] and SOX2 [58], which are essential for maintenance of the ES
cell pluripotency (Table S3 and Fig. 7B, C). Further, a few hepatic/
endoderm markers such as FOXA2, Alpha-fetoprotein, Albumin
(Fig. 7D–F) and miR-375 (Fig. 6B) were not upregulated, and there
was a concomitant increase in the expression of the ESC-specific
miR-302a* (Fig. 6C).
It is noteworthy that only one predicted target of miR-122
(NPEPPS) was significantly downregulated in wt versus mutant
miR-122-expressing cells, albeit relatively mildly (1.2-fold). Our
interpretation of this observation is that since we profiled gene
expression in 14d-differentiated cells stably expressing miR-122,
most of the detected changes in gene expression were a result of an
indirect rather than direct effect of miR-122.
We looked for enrichment in specific pathways among the
significantly differentially-expressed genes when comparing wt
versus mutant miR-122-expressing cells (using the Panther
classification system http://www.pantherdb.org/). We found one
significant enrichment (p,5.46xe
25) of the integrin signaling
pathway among the downregulated genes. Integrins can activate,
among others, the Grb2/Mek pathway [59], which was recently
shown to repress Nanog in murine ES cells differentiation towards
primitive endoderm [60]. Downregulation of members of the
integrin signaling pathway by miR-122 may lead, therefore, to de-
repression of Nanog, and consequently, to activation of hESC
markers including POU5F1 and SOX2 [61], as was observed in
our cells. Additionally, overexpression of miR-122 may have
affected global processing of miRNAs (DICER1 is a predicted
target of miR-122 according to TargetScan 4.0) and interfered
with the ESC differentiation, as it has been previously shown that
global loss of small RNAs in Dicer
2/2 mES cells results in a block
in ES cell differentiation [62].
Overall, overexpression of miR-122 alone in hESC was unable
to modify the mRNA profile of the cells towards an endodermal or
a hepatic pattern, but rather delayed the differentiation when
compared to mutant miRNA-expressing cells. Multiple reasons
may account for this result: many targets may not be expressed in
hESC; some of the targets may only be translationally repressed; it
could be that the level of the exogenous miRNA has not reached
the level observed in liver as early as seven weeks post-gestation,
and some effects may be difficult to detect with the tools and
experimental design of our study. Further, the most likely scenario
is that miR-122 may require additional miRNAs or proteins in
order to allow for differentiation,
In summary, miRNA expression profiling in hESC revealed three
novel undiscovered miRNAs, which will be uploaded to the miRbase
and given formal names. Upon treatment with NaB, induction of the
endodermal miR-122 and miR-375 was observed in parallel to
induction of hepatic gene expression, while ESC-specific miRNA
expression was reduced. Stable overexpression of endoderm-specific
miR-122 in hESC resulted in increased expression of a few
endodermal markers in spontaneously-differentiating hESC, but
had no clear effect on directing differentiation towards an
endodermal fate; rather, it delayed the general differentiation of
hESC. Overall, our results demonstrate that miRNA expression
correlates with gene expression in differentiated cells, and highlight
the potential role of miRNAs in endodermal differentiation of hESC.
Additional work is necessary to clarify the specific role of individual
miRNAs in endodermal and general hESC differentiation, and its
relevance to human embryonic development.
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